AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7002481 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (ultrasound)
Number of subjects: 60
Study 7002481 — intervention group
Group type: COMPARATOR
Intervention: Placebo physiotherapy with placebo tolmetin sodium
Number of subjects: 60
Study 31559422 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Rhodnius prolixus in rural dwellings
Number of subjects: 30
Study 31559422 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportions of males, females, and nymphs
Number of subjects: 30
Study 31559422 — intervention group
Group type: EXPERIMENTAL
Intervention: Density, crowding, and colonization indices
Number of subjects: 30
Study 31559422 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular analysis for T. cruzi DNA
Number of subjects: 30
Study 30012273 — intervention group
Group type: EXPERIMENTAL
Intervention: Peek school eye health system (smartphone-based sight test and referral system)
Number of subjects: 20563
Study 30012273 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Snellen's Tumbling‐E card and written referral)
Number of subjects: 20563
Study 30012273 — intervention group
Group type: EXPERIMENTAL
Intervention: Peek school eye health system
Number of subjects: 20563
Study 30012273 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 20563
Study 28433091 — intervention group
Group type: EXPERIMENTAL
Intervention: Cool Little Kids Online parenting program
Number of subjects: 433
Study 28433091 — intervention group
Group type: COMPARATOR
Intervention: Control group (24-week waitlist)
Number of subjects: 433
Study 26329674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high-volume hemofiltration (IHVHF)
Number of subjects: 51
Study 26329674 — intervention group
Group type: COMPARATOR
Intervention: Control group (SRD)
Number of subjects: 51
Study 24284101 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (ALA), 1.0 g, orally administered
Number of subjects: 66
Study 21034293 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress (Trier Social Stress Test)
Number of subjects: 32
Study 21034293 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 32
Study 18714218 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine-containing supplement (SUPP) - 201 mg of caffeine
Number of subjects: 31
Study 18714218 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC) - microcrystalline cellulose
Number of subjects: 31
Study 16353199 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1500 mg 3 times daily) plus vitamin D(3) 400 IU
Number of subjects: 19
Study 16353199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 16353199 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus vitamin D
Number of subjects: 19
Study 14723480 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent smoking cessation treatment offered during intensive rehabilitation for alcohol dependence.
Number of subjects: 499
Study 14723480 — intervention group
Group type: COMPARATOR
Intervention: Smoking cessation treatment offered six months following intensive rehabilitation for alcohol dependence.
Number of subjects: 499
Study 10200915 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week in-patient rehabilitation course
Number of subjects: 60
Study 10200915 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise recommendations)
Number of subjects: 60
Study 7773794 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydroxyethyl-starch/7.5% NaCl (HHT-HES)
Number of subjects: 40
Study 7773794 — intervention group
Group type: COMPARATOR
Intervention: 10% hydroxyethyl-starch/.9% NaCl (HES)
Number of subjects: 40
Study 2100976 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 0
Study 2100976 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0
Study 424688 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 565
Study 31097283 — intervention group
Group type: EXPERIMENTAL
Intervention: True electroacupuncture group (TEAG)
Number of subjects: 21
Study 31097283 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture group (SEAG)
Number of subjects: 21
Study 31097283 — intervention group
Group type: EXPERIMENTAL
Intervention: True electroacupuncture plus rehabilitation
Number of subjects: 21
Study 30155678 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangqi Decoction Granules (HQDG)
Number of subjects: 70
Study 30155678 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 70
Study 28652066 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder girdle stretching and strengthening with additional scapular stabilization exercises based on a kinetic chain approach
Number of subjects: 30
Study 28652066 — intervention group
Group type: COMPARATOR
Intervention: Shoulder girdle stretching and strengthening exercises only
Number of subjects: 30
Study 27144943 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative transthoracic echocardiography (TTE) findings
Number of subjects: 147
Study 24680572 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal polypropylene omega-3 mesh (group B)
Number of subjects: 92
Study 24680572 — intervention group
Group type: COMPARATOR
Intervention: Nonabsorbable sutures (group A)
Number of subjects: 92
Study 24680572 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study 22277092 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC with epirubicin or paclitaxel monotherapy
Number of subjects: 89
Study 19411450 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral fusion (fusion group, n = 37)
Number of subjects: 73
Study 19411450 — intervention group
Group type: COMPARATOR
Intervention: Without posterolateral fusion (nonfusion group, n = 36)
Number of subjects: 73
Study 19411450 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral fusion (fusion group)
Number of subjects: 73
Study 17204680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat robotic training
Number of subjects: 30
Study 17204680 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 30
Study 16343082 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth (group I)
Number of subjects: 40
Study 16343082 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination at 2 months (group II)
Number of subjects: 40
Study 16343082 — intervention group
Group type: COMPARATOR
Intervention: BCG vaccination (both groups)
Number of subjects: 40
Study 11991445 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg
Number of subjects: 225
Study 11991445 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 1.25 mg
Number of subjects: 225
Study 11991445 — intervention group
Group type: COMPARATOR
Intervention: E2/NETA (estradiol 2 mg plus norethindrone acetate 1 mg)
Number of subjects: 225
Study 9806503 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy (ChT) followed by standard radiation therapy (RT) (60 Gy in 6 weeks)
Number of subjects: 461
Study 9806503 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sequential and concurrent ChT and standard RT (60 Gy in 6 weeks)
Number of subjects: 461
Study 9806503 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent ChT and hyperfractionated RT (69.6 Gy in 6 weeks)
Number of subjects: 461
Study 9806503 — intervention group
Group type: COMPARATOR
Intervention: Sequential ChT followed by standard RT (60 Gy in 6 weeks)
Number of subjects: 461
Study 8536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard ramp distension with 4 mm Hg pressure step increments of 20 sec duration
Number of subjects: 7
Study 8536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow ramp distension with 2 mm Hg pressure increments of 40 sec duration
Number of subjects: 7
Study 8536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Random distension using a pressure ramp consisting of 2 mm Hg increments of 40 sec duration with randomly interposed pressure steps 50% below the preceding pressure step
Number of subjects: 7
Study 8536530 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid random distension with 4 mm Hg pressure increments of 10 sec duration with randomly interposed pressure steps 50% below the preceding pressure step
Number of subjects: 7
Study 29547448 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic training with pelvis assistance force
Number of subjects: 16
Study 29547448 — intervention group
Group type: COMPARATOR
Intervention: Treadmill-only training
Number of subjects: 16
Study 28435128 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track protocol (no preoperative bowel preparation, early restoration of diet, no postoperative antibiotics, early postoperative mobilization)
Number of subjects: 227
Study 28435128 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track protocol
Number of subjects: 227
Study 26228031 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 901
Study 26228031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 901
Study 24354899 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination-Young (GSD-Y) intervention
Number of subjects: 80
Study 24354899 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin pump training
Number of subjects: 80
Study 21236502 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (walking) for 8 weeks
Number of subjects: 0
Study 19803727 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV-7)
Number of subjects: 98
Study 19803727 — intervention group
Group type: COMPARATOR
Intervention: No vaccination (control group)
Number of subjects: 98
Study 17112807 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg/d for 8 days)
Number of subjects: 8
Study 15098972 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in combination with tretinoin and hydroquinone
Number of subjects: 0
Study 15098972 — intervention group
Group type: COMPARATOR
Intervention: Topical dexamethasone as monotherapy
Number of subjects: 0
Study 11739811 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNbeta-1b
Number of subjects: 718
Study 11739811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 718
Study 9010146 — intervention group
Group type: EXPERIMENTAL
Intervention: MGDF (0.03, 0.1, 0.3, 1.0, 3.0, or 5.0 microg/kg/day)
Number of subjects: 53
Study 9010146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 9010146 — intervention group
Group type: EXPERIMENTAL
Intervention: MGDF
Number of subjects: 53
Study 8116312 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy regimen with a platinum dose intensity of 8 mg/m2/week
Number of subjects: 294
Study 8116312 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychemotherapy regimen with a platinum dose intensity of 18 mg/m2/week
Number of subjects: 294
Study 8116312 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatinum and cisplatinum with a planned dose intensity of 43.75 mg/m2/week
Number of subjects: 294
Study 8116312 — intervention group
Group type: COMPARATOR
Intervention: Standard polychemotherapy (cyclophosphamide/cisplatinum) with a planned dose intensity of 25 mg/m2/week
Number of subjects: 294
Study 3687358 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting for 2, 10, 15, 20, or 25 minutes before transitioning to horizontal supine position
Number of subjects: 50
Study 29909708 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylactic mode (thrombopoietin, 15,000 units/day on days 2–11)
Number of subjects: 52
Study 29909708 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-chemo mode (thrombopoietin, 15,000 units/day on days -4, -2, and 2–9)
Number of subjects: 52
Study 29909708 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylactic mode
Number of subjects: 52
Study 29909708 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-chemo mode
Number of subjects: 52
Study 29909708 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modes
Number of subjects: 52
Study 27142805 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised confocal scanning laser indocyanine green angiography (ICGA)
Number of subjects: 34
Study 27142805 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening failures identified by imaging criteria
Number of subjects: 34
Study 25002391 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with blood pressure ≥ 140/90 mm Hg (experiment group)
Number of subjects: 1141
Study 25002391 — intervention group
Group type: COMPARATOR
Intervention: Patients with blood pressure <140/90 mm Hg (control group)
Number of subjects: 1141
Study 22699083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical anastomosis (stapler)
Number of subjects: 227
Study 22699083 — intervention group
Group type: COMPARATOR
Intervention: Manual anastomosis
Number of subjects: 227
Study 20525031 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatments for co-occurring SUD and PTSD (specifics not provided)
Number of subjects: 122
Study 18721084 — intervention group
Group type: EXPERIMENTAL
Intervention: T'ai chi chuan (TCC) training for 12 months
Number of subjects: 53
Study 18721084 — intervention group
Group type: COMPARATOR
Intervention: Usual-care (sedentary lifestyle)
Number of subjects: 53
Study 15972378 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (platinum-based regimens)
Number of subjects: 0
Study 15972378 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (specific regimens not detailed)
Number of subjects: 0
Study 15972378 — intervention group
Group type: COMPARATOR
Intervention: Control (no adjuvant chemotherapy)
Number of subjects: 0
Study 12904519 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel-node biopsy followed by axillary dissection only if the sentinel node contained metastases (sentinel-node group)
Number of subjects: 516
Study 12904519 — intervention group
Group type: COMPARATOR
Intervention: Sentinel-node biopsy and total axillary dissection (axillary-dissection group)
Number of subjects: 516
Study 10505538 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose hirudin
Number of subjects: 909
Study 10505538 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hirudin
Number of subjects: 909
Study 10505538 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 909
Study 10505538 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity warfarin (INR 2-2.5)
Number of subjects: 909
Study 10505538 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (aspirin alone)
Number of subjects: 909
Study 8525777 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit influenza vaccine (15 micrograms of each haemagglutinin strain)
Number of subjects: 51
Study 8525777 — intervention group
Group type: COMPARATOR
Intervention: Control group (not vaccinated)
Number of subjects: 51
Study 1751342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 248
Study 1751342 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 248
Study 7034773 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0
Study 7034773 — intervention group
Group type: COMPARATOR
Intervention: Untreated eyes (Control)
Number of subjects: 0
Study 30994376 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss (BWL) intervention
Number of subjects: 26
Study 30994376 — intervention group
Group type: COMPARATOR
Intervention: Recommended care (RC)
Number of subjects: 26
Study 28528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention targeting health professionals
Number of subjects: 88000
Study 28528578 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 88000
Study 28024715 — intervention group
Group type: COMPARATOR
Intervention: Standard anesthesia with thiopentone for induction and maintenance with isoflurane-fentanyl (Group A)
Number of subjects: 60
Study 28024715 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol for induction and maintenance along with fentanyl (Group B)
Number of subjects: 60
Study 25053514 — intervention group
Group type: COMPARATOR
Intervention: Single energy computed tomography (SECT) with full iodine volume load (group A)
Number of subjects: 80
Study 25053514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 50% iodine volume load (group B)
Number of subjects: 80
Study 25053514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 40% iodine volume load (group C)
Number of subjects: 80
Study 25053514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy computed tomography (DECT) with 30% iodine volume load (group D)
Number of subjects: 80
Study 22461416 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 9251
Study 22461416 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 9251
Study 22461416 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 9251
Study 22461416 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline apolipoprotein A-I
Number of subjects: 9251
Study 19721120 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal desensitisation plus motivational interviewing (IDMI)
Number of subjects: 68
Study 19721120 — intervention group
Group type: COMPARATOR
Intervention: Gamblers Anonymous (Control)
Number of subjects: 68
Study 17855054 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment
Number of subjects: 11
Study 17855054 — intervention group
Group type: COMPARATOR
Intervention: Control (no PRP)
Number of subjects: 11
Study 17855054 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP treatment
Number of subjects: 11
Study 15209305 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral vision practice
Number of subjects: 16
Study 15209305 — intervention group
Group type: EXPERIMENTAL
Intervention: Central vision practice
Number of subjects: 16
Study 11590456 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 192
Study 11590456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 9782034 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of the intercostobrachial nerve (ICBN)
Number of subjects: 120
Study 9782034 — intervention group
Group type: COMPARATOR
Intervention: Division of the intercostobrachial nerve (ICBN)
Number of subjects: 120
Study 7875838 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO suggested culture appropriate psychosocial Basic Test Battery
Number of subjects: 600
Study 7875838 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional assessment using Jellife's technique
Number of subjects: 600
Study 3168311 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI, 40 mg/day)
Number of subjects: 7
Study 3168311 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole + Sodium Ipodate (MMI + Na Ipodate, 1 g/day)
Number of subjects: 7
Study 3168311 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole + Saturated Solution of Potassium Iodide (MMI + SSKI, 6 drops twice daily)
Number of subjects: 7
Study 3168311 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 7
Study 31520301 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural weight management intervention
Number of subjects: 221
Study 31520301 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 221
Study 29723029 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvictimization profile
Number of subjects: 2776
Study 29723029 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessing profile
Number of subjects: 2776
Study 29723029 — intervention group
Group type: EXPERIMENTAL
Intervention: Low victimization profile
Number of subjects: 2776
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine spray 10 g/100 ml at 5 min before intercourse (G1)
Number of subjects: 78
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily (G2)
Number of subjects: 78
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil once daily plus lidocaine spray before planned sexual activity (G3)
Number of subjects: 78
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine spray (G1)
Number of subjects: 78
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (G2)
Number of subjects: 78
Study 28338191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil plus lidocaine spray (G3)
Number of subjects: 78
Study 25413592 — intervention group
Group type: EXPERIMENTAL
Intervention: LFQS + IPL
Number of subjects: 20
Study 25413592 — intervention group
Group type: COMPARATOR
Intervention: LFQS
Number of subjects: 20
Study 23375825 — intervention group
Group type: EXPERIMENTAL
Intervention: Lights Plus (immediate feedback to teens plus family access to event videos and ranking)
Number of subjects: 90
Study 23375825 — intervention group
Group type: COMPARATOR
Intervention: Lights Only (immediate feedback to teens)
Number of subjects: 90
Study 20636232 — intervention group
Group type: EXPERIMENTAL
Intervention: Polycystic ovary syndrome (PCOS) group
Number of subjects: 366
Study 20636232 — intervention group
Group type: COMPARATOR
Intervention: Control group (tubal factor)
Number of subjects: 366
Study 20636232 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PCOS and control)
Number of subjects: 366
Study 19273708 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrecolomab (ED) plus fluorouracil (FU) based therapy
Number of subjects: 1839
Study 19273708 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil (FU) based therapy alone
Number of subjects: 1839
Study 17363845 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 5-40 mg
Number of subjects: 16876
Study 17363845 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16876
Study 17363845 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin < or = 20 mg
Number of subjects: 16876
Study 17363845 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin
Number of subjects: 16876
Study 17363845 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin < or = 40 mg
Number of subjects: 16876